OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.

PubMed

Year: 1994
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: L M Weiner, W Li, M Holmes, R B Catalano, M Dovnarsky, K Padavic, R K Alpaugh
Institution: Fox Chase Cancer Center
Language: English

Topic: Neutropenia and Cancer Infections
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: macrophage colony-stimulating factor, interferon-gamma, combination therapy, monocytosis, thrombocytopenia, drug toxicity, Fc gamma receptor III, CD16, monocyte activation, CD14, maximum tolerated dose, hepatotoxicity, chronic obstructive pulmonary disease, mononuclear phagocytes, continuous infusion, immunomodulation
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: Antibody-Targeted Cancer Immunotherapy, Comprehensive Cancer Center Program at Fox Chase
OpenAlex ID: W2125237590
FWCI: 3.599
Cites: 17
Cited by: 104
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms